Library / Laws / 115th Congress / House Bills / H.R. 2113
H.R. 2113
To require the Food and Drug Administration to expedite review of pharmaceuticals that are approved for marketing in the European Union.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2017-04-20 | 1.2K | ⠃⠗⠋ |